Difficulty: Medium
Average Score: 75%
Practice
Indicate the competitive antagonist of BZ receptors:
Correct answer
A
Rationale
The correct answer is A) Flumazenil, which acts as a competitive antagonist of BZ (benzodiazepine) receptors. Flumazenil is used as a specific antidote for benzodiazepine overdose by competitively binding to the BZ receptors and displacing the benzodiazepines, reversing their effects.
Option B) Buspirone is a partial agonist of serotonin receptors and is used to treat anxiety disorders. It does not interact with BZ receptors.
Option C) Picrotoxin is a noncompetitive antagonist of GABA receptors, not BZ receptors.
Option D) Diazepam is a benzodiazepine drug that acts as a positive allosteric modulator of the GABA-A receptor, enhancing the inhibitory effects of GABA, but it is not a competitive antagonist of BZ receptors.
Understanding the mechanisms of action of different pharmacological agents is crucial in pharmacology across the lifespan. It is important for healthcare professionals to be able to differentiate between different drug classes, their specific receptor interactions, and their clinical applications to make informed decisions in patient care.
Option B) Buspirone is a partial agonist of serotonin receptors and is used to treat anxiety disorders. It does not interact with BZ receptors.
Option C) Picrotoxin is a noncompetitive antagonist of GABA receptors, not BZ receptors.
Option D) Diazepam is a benzodiazepine drug that acts as a positive allosteric modulator of the GABA-A receptor, enhancing the inhibitory effects of GABA, but it is not a competitive antagonist of BZ receptors.
Understanding the mechanisms of action of different pharmacological agents is crucial in pharmacology across the lifespan. It is important for healthcare professionals to be able to differentiate between different drug classes, their specific receptor interactions, and their clinical applications to make informed decisions in patient care.